• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用质量源于设计方法开发并表征一种含婆那伽磷脂复合物的纳米药物递送系统以提高生物利用度。

Development and characterization of a nano-drug delivery system containing vasaka phospholipid complex to improve bioavailability using quality by design approach.

作者信息

Nandhini Sundaresan, Ilango Kaliappan

机构信息

Divison of Pharmacognosy and Phytochemistry, Interdisciplinary Institute of Indian System of Medicine (IIISM), SRM Institute of Science and Technology, Kattankulathur-603 203, Chengalpattu (Dt), Tamil Nadu, India.

Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur-603 203, Chengalpattu (Dt), Tamil Nadu, India.

出版信息

Res Pharm Sci. 2020 Dec 30;16(1):103-117. doi: 10.4103/1735-5362.305193. eCollection 2021 Feb.

DOI:10.4103/1735-5362.305193
PMID:33953779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8074810/
Abstract

BACKGROUND AND PURPOSE

Vasicine is a potential bronchodilator and can be used for the effective management of asthma and bronchitis. It has low absorption in the gastrointestinal tract due to its poor solubility thereby low bioavailability. The objective of this research was to develop a novel drug delivery system of vasaka extract to improve its bioavailability by enhancing the solubility and absorption of vasicine.

EXPERIMENTAL APPROACH

Vasaka-loaded phytosomes were developed and optimized by thin-layer hydration technique using systematic quality by design approach. Box-Behnken design (3 factorial design) using Design-Expert software was employed to optimize phytosome wherein phosphatidylcholine concentration (X), stirring temperature (X), and stirring time (X) were selected as independent variables. Yield (%), particle size (nm), and entrapment efficiency (%) were evaluated as responses. The optimized phytosome was characterized by studying the surface morphology such as FE-SEM and TEM analysis, thermal characteristics by thermal gravimetric analysis and spectral and diffraction studies by FTIR and XRD analysis and studying the dissolution behaviour of phytosome by release study.

FINDINGS/RESULTS: The percentage yield, particle size, and entrapment efficiency values of the phytosomes were found in the range of 30.03-97.03%, 231.0-701.4 nm, and 20.02-95.88% w/w, respectively. The optimized phytosome showed the zeta potential of -23.2 mV exhibited good stability and SEM and TEM analysis revealed the spherical shape and smooth particles with the uniform particle size distribution of phytosomes. The comparative drug release study of vasaka extract and phytosome revealed the sustained release characteristics of phytosome which reached 68.80% at 8 h compared to vasaka extract reached a maximum of 45.08% at 4 h.

CONCLUSION AND IMPLICATION

The results highlighted the importance of optimization of formulation development using quality by design strategy to achieve consistent quality of pharmaceutical products.

摘要

背景与目的

鸭嘴花碱是一种潜在的支气管扩张剂,可用于有效治疗哮喘和支气管炎。由于其溶解性差,在胃肠道中的吸收较低,因此生物利用度低。本研究的目的是开发一种新型的鸭嘴花提取物药物递送系统,通过提高鸭嘴花碱的溶解度和吸收来提高其生物利用度。

实验方法

采用系统的质量源于设计方法,通过薄层水化技术制备并优化了载鸭嘴花碱的植物脂质体。使用Design-Expert软件的Box-Behnken设计(3因素设计)来优化植物脂质体,其中选择磷脂酰胆碱浓度(X1)、搅拌温度(X2)和搅拌时间(X3)作为自变量。将产率(%)、粒径(nm)和包封率(%)作为响应指标进行评估。通过研究表面形态(如场发射扫描电子显微镜和透射电子显微镜分析)、热重分析的热特性、傅里叶变换红外光谱和X射线衍射分析的光谱和衍射研究以及通过释放研究来研究植物脂质体的溶解行为,对优化后的植物脂质体进行表征。

研究结果

植物脂质体的产率、粒径和包封率分别在30.03 - 97.03%、231.0 - 701.4 nm和20.02 - 95.88% w/w范围内。优化后的植物脂质体的ζ电位为-23.2 mV,表现出良好的稳定性,扫描电子显微镜和透射电子显微镜分析显示其呈球形,颗粒光滑,粒径分布均匀。鸭嘴花提取物与植物脂质体的对比药物释放研究表明,植物脂质体具有缓释特性,在8小时时达到68.80%,而鸭嘴花提取物在4小时时最高达到45.08%。

结论与意义

结果强调了使用质量源于设计策略优化制剂开发以实现药品质量一致性的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/7e32855207cf/RPS-16-103-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/8cf992cabfb4/RPS-16-103-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/9ff280e25dd4/RPS-16-103-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/1f0ee0b431dc/RPS-16-103-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/92f42a3b8e92/RPS-16-103-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/3cb1edb84e7a/RPS-16-103-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/44f61f55c193/RPS-16-103-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/d891e084c1ab/RPS-16-103-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/a3397f1fa042/RPS-16-103-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/291e25c05825/RPS-16-103-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/86ed21803184/RPS-16-103-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/fcc28a570e6a/RPS-16-103-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/35b0d7a8443e/RPS-16-103-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/387a1176fa4d/RPS-16-103-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/7e32855207cf/RPS-16-103-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/8cf992cabfb4/RPS-16-103-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/9ff280e25dd4/RPS-16-103-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/1f0ee0b431dc/RPS-16-103-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/92f42a3b8e92/RPS-16-103-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/3cb1edb84e7a/RPS-16-103-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/44f61f55c193/RPS-16-103-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/d891e084c1ab/RPS-16-103-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/a3397f1fa042/RPS-16-103-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/291e25c05825/RPS-16-103-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/86ed21803184/RPS-16-103-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/fcc28a570e6a/RPS-16-103-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/35b0d7a8443e/RPS-16-103-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/387a1176fa4d/RPS-16-103-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/8074810/7e32855207cf/RPS-16-103-g016.jpg

相似文献

1
Development and characterization of a nano-drug delivery system containing vasaka phospholipid complex to improve bioavailability using quality by design approach.采用质量源于设计方法开发并表征一种含婆那伽磷脂复合物的纳米药物递送系统以提高生物利用度。
Res Pharm Sci. 2020 Dec 30;16(1):103-117. doi: 10.4103/1735-5362.305193. eCollection 2021 Feb.
2
Optimization and Characterization of Cuscuta reflexa Extract Loaded Phytosomes by the Box-Behnken Design to Improve the Oral Bioavailability.采用 Box-Behnken 设计优化并表征菟丝子提取物负载的植物甾醇体,以提高口服生物利用度。
J Oleo Sci. 2022 Apr 29;71(5):671-683. doi: 10.5650/jos.ess21318. Epub 2022 Apr 5.
3
Fabrication of Phytosome with Enhanced Activity of : Formulation Modeling and in vivo Antimalarial Study.活性增强的植物药质体的制备:制剂建模及体内抗疟研究
Int J Nanomedicine. 2024 Sep 11;19:9411-9435. doi: 10.2147/IJN.S467811. eCollection 2024.
4
Phytosome complexed with chitosan for gingerol delivery in the treatment of respiratory infection: In vitro and in vivo evaluation.姜辣素传递用植素复合壳聚糖治疗呼吸道感染的研究:体外与体内评价。
Eur J Pharm Sci. 2018 Sep 15;122:214-229. doi: 10.1016/j.ejps.2018.06.028. Epub 2018 Jun 30.
5
Formulation and characterization of an apigenin-phospholipid phytosome (APLC) for improved solubility, in vivo bioavailability, and antioxidant potential.用于改善溶解度、体内生物利用度和抗氧化潜力的芹菜素-磷脂植物药(APLC)的制剂与表征
Eur J Pharm Sci. 2017 Oct 15;108:36-49. doi: 10.1016/j.ejps.2016.12.009. Epub 2016 Dec 8.
6
Optimization and development of antidiabetic phytosomes by the Box-Behnken design.采用 Box-Behnken 设计优化和开发抗糖尿病植物药。
J Liposome Res. 2018 Jun;28(2):161-172. doi: 10.1080/08982104.2017.1311913. Epub 2017 Apr 17.
7
Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.通过Box-Behnken设计改善扎来普隆口服给药的脂质纳米颗粒:优化、体外和体内评价
Drug Dev Ind Pharm. 2017 Jul;43(7):1205-1214. doi: 10.1080/03639045.2017.1304957. Epub 2017 Mar 26.
8
Designing and fabrication of colloidal nano-phytosomes with gamma-oryzanol and phosphatidylcholine for encapsulation and delivery of polyphenol-rich extract from pomegranate peel.设计并制备含有γ-谷维素和磷脂酰胆碱的胶体纳米植物磷脂囊泡,用于包封和递送石榴皮中富含多酚的提取物。
Int J Biol Macromol. 2024 Jan;256(Pt 2):128501. doi: 10.1016/j.ijbiomac.2023.128501. Epub 2023 Nov 29.
9
Phytosomes loaded with mitomycin C-soybean phosphatidylcholine complex developed for drug delivery.载有丝裂霉素 C-大豆卵磷脂复合物的植物体,用于药物传递。
Mol Pharm. 2013 Jan 7;10(1):90-101. doi: 10.1021/mp300489p. Epub 2012 Nov 29.
10
Carvacrol-Loaded Phytosomes for Enhanced Wound Healing: Molecular Docking, Formulation, DoE-Aided Optimization, and in vitro/in vivo Evaluation.负载香芹酚的植物甾醇体促进伤口愈合的研究:分子对接、制剂学、基于设计实验的优化、以及体内外评价。
Int J Nanomedicine. 2023 Oct 12;18:5749-5780. doi: 10.2147/IJN.S421617. eCollection 2023.

引用本文的文献

1
Systematic Review of the Antitumor Activities and Mechanisms of Scorpion Venom on Human Breast Cancer Cells Lines (In Vitro Study).蝎毒对人乳腺癌细胞系的抗肿瘤活性及作用机制的系统评价(体外研究)
J Clin Med. 2025 May 4;14(9):3181. doi: 10.3390/jcm14093181.
2
Fabrication of Phytosome with Enhanced Activity of : Formulation Modeling and in vivo Antimalarial Study.活性增强的植物药质体的制备:制剂建模及体内抗疟研究
Int J Nanomedicine. 2024 Sep 11;19:9411-9435. doi: 10.2147/IJN.S467811. eCollection 2024.
3
Nanophytosome formulation of β-1,3-glucan and extract for drug delivery applications.

本文引用的文献

1
High-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) as a tool in the determination of biomarkers of Passiflora-based herbal medicines.高分辨率魔角旋转核磁共振(HR-MAS NMR)作为一种工具,用于测定基于 Passiflora 的草药生物标志物。
Fitoterapia. 2020 Apr;142:104500. doi: 10.1016/j.fitote.2020.104500. Epub 2020 Feb 8.
2
Prevalence of use and reported side effects of herbal medicine among adults in Saudi Arabia.沙特阿拉伯成年人中草药使用情况及报告的副作用发生率。
Complement Ther Med. 2020 Jan;48:102255. doi: 10.1016/j.ctim.2019.102255. Epub 2019 Nov 25.
3
Understanding the effect of lipid formulation loading and ethanol as a diluent on solidification of pitavastatin super-saturable SNEDDS using factorial design approach.
用于药物递送应用的β-1,3-葡聚糖纳米植物体配方及提取物
MethodsX. 2023 Nov 20;11:102480. doi: 10.1016/j.mex.2023.102480. eCollection 2023 Dec.
4
Overview of phytosomes in treating cancer: Advancement, challenges, and future outlook.植物药脂质体治疗癌症概述:进展、挑战与未来展望
Heliyon. 2023 May 24;9(6):e16561. doi: 10.1016/j.heliyon.2023.e16561. eCollection 2023 Jun.
5
Development and evaluation of polycaprolactone-based electrospun nanofibers containing timolol maleate as a sustained-release device for treatment of glaucoma: evaluation in equine eye.含马来酸噻吗洛尔的聚己内酯基电纺纳米纤维作为青光眼治疗缓释装置的研制与评价:在马眼中的评价
Res Pharm Sci. 2022 Sep 8;17(5):468-481. doi: 10.4103/1735-5362.355196. eCollection 2022 Oct.
6
Design and optimization of cranberry extract loaded bile salt augmented liposomes for targeting of MCP-1/STAT3/VEGF signaling pathway in DMN-intoxicated liver in rats.设计并优化负载熊果酸的胆汁盐增强型脂质体,用于靶向 DMN 诱导的大鼠肝损伤中 MCP-1/STAT3/VEGF 信号通路。
Drug Deliv. 2022 Dec;29(1):427-439. doi: 10.1080/10717544.2022.2032875.
7
Scorpion Venom-Functionalized Quercetin Phytosomes for Breast Cancer Management: In Vitro Response Surface Optimization and Anticancer Activity against MCF-7 Cells.用于乳腺癌治疗的蝎毒功能化槲皮素磷脂体:体外响应面优化及对MCF-7细胞的抗癌活性
Polymers (Basel). 2021 Dec 27;14(1):93. doi: 10.3390/polym14010093.
8
Extract-phospholipid Complex: Preparation and Initial Pharmacodynamics Research in Rats.提取磷脂复合物的制备及其在大鼠体内的初步药效学研究。
Curr Pharm Biotechnol. 2022;23(6):847-860. doi: 10.2174/1389201022666210729142257.
采用析因设计方法了解脂质制剂载药量和乙醇作为稀释剂对匹伐他汀超饱和自乳化药物递送系统固化的影响。
Res Pharm Sci. 2019 Oct 4;14(5):378-390. doi: 10.4103/1735-5362.268198. eCollection 2019 Oct.
4
Enhanced sustained release of furosemide in long circulating chitosan-conjugated PLGA nanoparticles.速尿在长循环壳聚糖共轭聚乳酸-羟基乙酸共聚物纳米粒中的缓释增强
Res Pharm Sci. 2019 Mar 8;14(2):93-106. doi: 10.4103/1735-5362.253356. eCollection 2019 Apr.
5
An analytical strategy to explore the multicomponent pharmacokinetics of herbal medicine independently of standards: Application in Gelsemium elegans extracts.一种独立于标准探索草药多成分药代动力学的分析策略:在钩吻提取物中的应用。
J Pharm Biomed Anal. 2019 Nov 30;176:112833. doi: 10.1016/j.jpba.2019.112833. Epub 2019 Aug 23.
6
The Why, Where, Who, How, and What of the vesicular delivery systems.囊泡递药系统的来龙去脉。
Adv Colloid Interface Sci. 2019 Sep;271:101985. doi: 10.1016/j.cis.2019.07.006. Epub 2019 Jul 9.
7
Quality by design driven development of resveratrol loaded ethosomal hydrogel for improved dermatological benefits via enhanced skin permeation and retention.基于质量源于设计的白藜芦醇醇质体水凝胶的研制,通过增强皮肤渗透和滞留以提高其在皮肤病学方面的效益。
Int J Pharm. 2019 Aug 15;567:118448. doi: 10.1016/j.ijpharm.2019.118448. Epub 2019 Jun 18.
8
Optimization of Nanostructured Lipid Carriers of Lurasidone Hydrochloride Using Box-Behnken Design for Brain Targeting: In Vitro and In Vivo Studies.盐酸鲁拉西酮纳米结构脂质载体的 Box-Behnken 设计优化及其脑靶向性的体内外研究。
J Pharm Sci. 2019 Sep;108(9):3082-3090. doi: 10.1016/j.xphs.2019.05.001. Epub 2019 May 8.
9
QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment.基于质量源于设计的早期药物研发研究:高压均质法生产用于皮肤癌治疗的脂质纳米粒。
Int J Pharm. 2019 May 30;563:110-121. doi: 10.1016/j.ijpharm.2019.03.056. Epub 2019 Mar 29.
10
Purple heart plant leaves extract-mediated silver nanoparticle synthesis: Optimization by Box-Behnken design.紫心草叶片提取物介导的银纳米粒子合成:Box-Behnken 设计优化。
Mater Sci Eng C Mater Biol Appl. 2019 Jun;99:1105-1114. doi: 10.1016/j.msec.2019.02.061. Epub 2019 Feb 15.